nifedipine has been researched along with Recrudescence in 79 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The rationale for the use of nifedipine in patients with acute myocardial infarction (MI) is based on the various cardiovascular actions of the compound: reduction of myocardial oxygen consumption by attenuation of cardiac and vascular smooth muscle tension; augmentation of oxygen and substrate supply after increased coronary blood flow with dilatation of epicardial coronary arteries (particularly in coronary obstructions) and dilatation of coronary resistance and collateral vessels; myocardial 'protection', i." | 10.16 | Myocardial infarction. Secondary prevention with nifedipine. ( Ebner, F; Rafflenbeul, W, 1991) |
| "We examined the effect of a Ca antagonist (nilvadipine) on the occurrence or recurrence of symptomatic stroke in hypertensive patients with MRI-defined asymptomatic cerebral infarction (ACI), periventricular hyperintensity (PVH), and deep and subcortical white matter hyperintensity (DSWMH), with or without a history of stroke, and evaluated the effect of long-term treatment on the lesions." | 9.12 | Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA Study). 1. Design and results at enrollment. ( Fukuuchi, Y; Hirai, S; Okudera, T; Shinohara, Y; Terashi, A; Tohgi, H; Yamaguchi, T, 2007) |
| "Our study clearly demonstrates that the therapeutic use of topical nifedipine and lidocaine ointment should be extended to the conservative treatment of chronic anal fissure." | 9.10 | Topical nifedipine with lidocaine ointment vs. active control for treatment of chronic anal fissure: results of a prospective, randomized, double-blind study. ( Antropoli, C; Antropoli, M; Attena, F; Balzano, A; Bove, A; De Stefano, G; Molino, D; Perrotti, P, 2002) |
| "A total of 1054 postmyocardial infarction patients were divided randomly into those being treated with calcium antagonists (n = 566 [nifedipine, 425 patients and diltiazem, 141 patients]) and controls (no calcium antagonist; n = 488)." | 9.09 | Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group. ( Ishikawa, K; Kanamasa, K; Kimura, A; Miyataka, M; Takenaka, T, 1999) |
| "This study was intended to determine the 5-year mortality of 2138 post-myocardial infarction (MI) patients who took part in the Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT)." | 9.08 | Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial. ( Behar, S; Boyko, V; Goldbourt, U; Kaplinsky, E; Mandelzweig, L; Reicher-Reiss, H, 1998) |
| "This study showed that use of short-acting nifedipine and diltiazem in this postmyocardial infarction population was associated with a 24% higher cardiac event rate, but this strong adverse trend did not reach statistical significance." | 9.08 | Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. ( Hama, J; Ishikawa, K; Kanamasa, K; Katori, R; Kimura, A; Nakai, S; Ogawa, I; Oyaizu, M; Takenaka, T; Yabushita, H; Yamamoto, K; Yamamoto, T, 1997) |
| " The purpose of this study was to assess the risk ratio for cancer mortality associated with nifedipine in a large population of patients post-myocardial infarction." | 9.08 | Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction. ( Behar, S; Boyko, V; Goldbourt, U; Jonas, M; Mandelzweig, L; Reicher-Reiss, H, 1998) |
| "To ascertain whether predischarge arteriography is beneficial in patients with acute myocardial infarction treated with recombinant tissue-type plasminogen activator (rt-PA), heparin and aspirin, the outcome of 197 patients in the Thrombolysis in Myocardial Infarction (TIMI) IIA study assigned to conservative management and routine predischarge coronary arteriography (routine catheterization group) was compared with the outcome of 1,461 patients from the TIMI IIB study assigned to conservative management without routine coronary arteriography unless ischemia recurred spontaneously or on predischarge exercise testing (selective catheterization group)." | 9.07 | Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators. ( Babb, JD; Baim, DS; Braunwald, E; Chesebro, JH; Frederick, M; Gore, JM; Passamani, ER; Roberts, R; Rogers, WJ; Williams, DO, 1991) |
| "14 CCUs in Israel participated in a double-blind, placebo controlled, randomized trial of nifedipine, 30 mg/day, for the secondary prevention of myocardial infarction (MI)." | 9.06 | [Nifedipine in secondary prevention after myocardial infarction. SPRINT Study Group]. ( , 1989) |
| "We aimed to evaluate efficacy and safety of the use of nifedipine gel with lidocaine in the treatment of acute anal fissures in children by reviewing the cases of 106 children with acute anal fissure treated conservatively by nifedipine gel with lidocaine between the years 2003-2012." | 7.83 | Anal fissure in children: a 10-year clinical experience with nifedipine gel with lidocaine. ( Abu-Kishk, I; Berkovitch, M; Efrati, Y; Klin, B, 2016) |
| "In a young woman with primary pulmonary hypertension, treatment with low-dose nifedipine resulted in resolution of symptoms and of tricuspid regurgitation." | 7.70 | Rapid recurrence of pulmonary hypertension following cessation of nifedipine. ( Fennell, WH; Gallagher, MM; Hart, CM; Vaughan, CJ, 1998) |
| "The efficacy of nifedipine in relieving recurrent ischemic episodes following acute myocardial infarction was studied in 11 patients a mean of 9." | 7.66 | Nifedipine therapy for recurrent ischemic pain following myocardial infarction. ( Muller, JE; Stone, PH, 1982) |
| "In conclusion, we observed first that nifedipine is highly efficacious in preventing the coronary vasospasm of Prinzmetal's variant angina." | 7.66 | Nifedipine therapy for coronary vasospasm. ( Antman, EM; Muller, JE; Stone, PH, 1983) |
| "Three patients with non-Hodgkin's lymphoma who relapsed and were considered to be resistant to standard chemotherapeutic agents including vinca alkaloids were treated with a vinca alkaloid combined with calcium antagonist, nicardipine." | 7.66 | [Combination therapy of vinca alkaloids and nicardipine in non-Hodgkin's lymphoma with resistant to various antineoplastic agents]. ( Hattori, M; Honda, T; Sampi, K, 1983) |
| "Nifedipine was applied for the secondary prophylaxis of affective phasic disorders." | 6.68 | [A trial of the use of nifedipine for preventing relapses in affective and schizoaffective psychoses]. ( Snedkova, LV, 1996) |
| "The rationale for the use of nifedipine in patients with acute myocardial infarction (MI) is based on the various cardiovascular actions of the compound: reduction of myocardial oxygen consumption by attenuation of cardiac and vascular smooth muscle tension; augmentation of oxygen and substrate supply after increased coronary blood flow with dilatation of epicardial coronary arteries (particularly in coronary obstructions) and dilatation of coronary resistance and collateral vessels; myocardial 'protection', i." | 6.16 | Myocardial infarction. Secondary prevention with nifedipine. ( Ebner, F; Rafflenbeul, W, 1991) |
| "Risk factors for preterm labor commonly observed in the study group were urinary tract infection (60." | 5.39 | Pregnancy outcomes and successful rate of nifedipine therapeutic protocol implementation in a hospital of San Juan. ( Catalano, LN; Negron, I; Rivera Rosa, E; Vázquez Guzmán, M; Villar Diaz, M, 2013) |
| "Nifedipine was administered in 20 mg doses hourly during right cardiac catheterization and was repeated after 1 hour until a decrease in systemic pressure occurred." | 5.29 | [Effect of large doses of nifedipine on pulmonary hypertension in patients with recurrent pulmonary thromboembolism]. ( Fijałkowska, A; Filipecki, S; Hajduk, B; Pałasiewicz, G; Polowiec, Z; Radomyski, A; Tomkowski, W, 1994) |
| "We examined pregnancy outcomes in women receiving nifedipine tocolysis having recurrent preterm labor (RPTL)." | 5.14 | An examination of the clinical benefits and cost-effectiveness of tocolytic replacement following recurrent preterm labor. ( de la Torre, L; Desch, C; Flick, AA; González-Quintero, VH; Istwan, N; Rhea, D; Roca, LE, 2010) |
| "We examined the effect of a Ca antagonist (nilvadipine) on the occurrence or recurrence of symptomatic stroke in hypertensive patients with MRI-defined asymptomatic cerebral infarction (ACI), periventricular hyperintensity (PVH), and deep and subcortical white matter hyperintensity (DSWMH), with or without a history of stroke, and evaluated the effect of long-term treatment on the lesions." | 5.12 | Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA Study). 1. Design and results at enrollment. ( Fukuuchi, Y; Hirai, S; Okudera, T; Shinohara, Y; Terashi, A; Tohgi, H; Yamaguchi, T, 2007) |
| "Our study clearly demonstrates that the therapeutic use of topical nifedipine and lidocaine ointment should be extended to the conservative treatment of chronic anal fissure." | 5.10 | Topical nifedipine with lidocaine ointment vs. active control for treatment of chronic anal fissure: results of a prospective, randomized, double-blind study. ( Antropoli, C; Antropoli, M; Attena, F; Balzano, A; Bove, A; De Stefano, G; Molino, D; Perrotti, P, 2002) |
| "A total of 1054 postmyocardial infarction patients were divided randomly into those being treated with calcium antagonists (n = 566 [nifedipine, 425 patients and diltiazem, 141 patients]) and controls (no calcium antagonist; n = 488)." | 5.09 | Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group. ( Ishikawa, K; Kanamasa, K; Kimura, A; Miyataka, M; Takenaka, T, 1999) |
| "This study showed that use of short-acting nifedipine and diltiazem in this postmyocardial infarction population was associated with a 24% higher cardiac event rate, but this strong adverse trend did not reach statistical significance." | 5.08 | Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. ( Hama, J; Ishikawa, K; Kanamasa, K; Katori, R; Kimura, A; Nakai, S; Ogawa, I; Oyaizu, M; Takenaka, T; Yabushita, H; Yamamoto, K; Yamamoto, T, 1997) |
| "This study was intended to determine the 5-year mortality of 2138 post-myocardial infarction (MI) patients who took part in the Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT)." | 5.08 | Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial. ( Behar, S; Boyko, V; Goldbourt, U; Kaplinsky, E; Mandelzweig, L; Reicher-Reiss, H, 1998) |
| " The purpose of this study was to assess the risk ratio for cancer mortality associated with nifedipine in a large population of patients post-myocardial infarction." | 5.08 | Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction. ( Behar, S; Boyko, V; Goldbourt, U; Jonas, M; Mandelzweig, L; Reicher-Reiss, H, 1998) |
| "To ascertain whether predischarge arteriography is beneficial in patients with acute myocardial infarction treated with recombinant tissue-type plasminogen activator (rt-PA), heparin and aspirin, the outcome of 197 patients in the Thrombolysis in Myocardial Infarction (TIMI) IIA study assigned to conservative management and routine predischarge coronary arteriography (routine catheterization group) was compared with the outcome of 1,461 patients from the TIMI IIB study assigned to conservative management without routine coronary arteriography unless ischemia recurred spontaneously or on predischarge exercise testing (selective catheterization group)." | 5.07 | Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators. ( Babb, JD; Baim, DS; Braunwald, E; Chesebro, JH; Frederick, M; Gore, JM; Passamani, ER; Roberts, R; Rogers, WJ; Williams, DO, 1991) |
| "14 CCUs in Israel participated in a double-blind, placebo controlled, randomized trial of nifedipine, 30 mg/day, for the secondary prevention of myocardial infarction (MI)." | 5.06 | [Nifedipine in secondary prevention after myocardial infarction. SPRINT Study Group]. ( , 1989) |
| "To evaluate the protective effect of nifedipine on ischemic myocardium, in addition to thrombolytic therapy, a total of 149 patients with acute myocardial infarction were included in a double-blind controlled study in which they received 20 mg sublingual nifedipine (74 patients in group 1) or placebo (75 patients in group 2) in the emergency ward, either intracoronary nifedipine, 0." | 5.06 | Combination of calcium channel blocker and thrombolytic therapy in acute myocardial infarction. ( Erbel, R; Henrichs, KJ; Meinertz, T; Meyer, J; Olshausen, KV; Pop, T; Rupprecht, HJ; Schlürmann, W; Schuster, CJ; Treese, N, 1988) |
| "We aimed to evaluate efficacy and safety of the use of nifedipine gel with lidocaine in the treatment of acute anal fissures in children by reviewing the cases of 106 children with acute anal fissure treated conservatively by nifedipine gel with lidocaine between the years 2003-2012." | 3.83 | Anal fissure in children: a 10-year clinical experience with nifedipine gel with lidocaine. ( Abu-Kishk, I; Berkovitch, M; Efrati, Y; Klin, B, 2016) |
| "In a young woman with primary pulmonary hypertension, treatment with low-dose nifedipine resulted in resolution of symptoms and of tricuspid regurgitation." | 3.70 | Rapid recurrence of pulmonary hypertension following cessation of nifedipine. ( Fennell, WH; Gallagher, MM; Hart, CM; Vaughan, CJ, 1998) |
| "Drug-induced gingival overgrowth (DGO) is one of the well-recognized side effects of cyclosporin A (CsA) or nifedipine (Ni)." | 3.70 | Effectiveness of periodontal therapy in patients with drug-induced gingival overgrowth. Long-term results. ( Atilla, G; Baylas, H; Ilgenli, T, 1999) |
| "The effect of a single dose of nifedipine or propranolol hydrochloride on gastric acid production and motility has been assessed in 90 duodenal ulcer (DU) patients having the relapse." | 3.69 | [The effect of calcium antagonists and beta-adrenoblockaders on disordered stomach functions in patients with duodenal peptic ulcer]. ( Budnik, IuB; Syman, LN; Tsimmerman, IaS, 1994) |
| " Nifedipine, a calcium antagonist, was added to the current medical therapy consisting of maximal doses of beta blockers and nitrates in a group of 18 patients who had had one revascularization procedure and subsequently had class 3 and 4 angina pectoris." | 3.67 | Angina after aortocoronary bypass grafting: combined medical therapy including nifedipine. ( Assey, ME; Hanger, KH, 1985) |
| "The efficacy of nifedipine in relieving recurrent ischemic episodes following acute myocardial infarction was studied in 11 patients a mean of 9." | 3.66 | Nifedipine therapy for recurrent ischemic pain following myocardial infarction. ( Muller, JE; Stone, PH, 1982) |
| "Three patients with non-Hodgkin's lymphoma who relapsed and were considered to be resistant to standard chemotherapeutic agents including vinca alkaloids were treated with a vinca alkaloid combined with calcium antagonist, nicardipine." | 3.66 | [Combination therapy of vinca alkaloids and nicardipine in non-Hodgkin's lymphoma with resistant to various antineoplastic agents]. ( Hattori, M; Honda, T; Sampi, K, 1983) |
| "In conclusion, we observed first that nifedipine is highly efficacious in preventing the coronary vasospasm of Prinzmetal's variant angina." | 3.66 | Nifedipine therapy for coronary vasospasm. ( Antman, EM; Muller, JE; Stone, PH, 1983) |
| "Nifedipine was applied for the secondary prophylaxis of affective phasic disorders." | 2.68 | [A trial of the use of nifedipine for preventing relapses in affective and schizoaffective psychoses]. ( Snedkova, LV, 1996) |
| "Thus, remediable coronary vasospasm is not likely to be a major cause of post infarction ischemia in patients with nontransmural infarction." | 2.66 | Chest pain after nontransmural infarction: the absence of remediable coronary vasospasm. ( Biello, DR; Eisenberg, PR; Geltman, EM; Jaffe, AS; Lee, RG, 1985) |
| "Risk factors for preterm labor commonly observed in the study group were urinary tract infection (60." | 1.39 | Pregnancy outcomes and successful rate of nifedipine therapeutic protocol implementation in a hospital of San Juan. ( Catalano, LN; Negron, I; Rivera Rosa, E; Vázquez Guzmán, M; Villar Diaz, M, 2013) |
| "The case of an 83-year-old man with colon cancer who developed chest pain during 5-FU infusion is presented." | 1.38 | A case of severe coronary spasm associated with 5-fluorouracil chemotherapy. ( Cho, WH; Choi, SK; Kim, SB; Kim, SM; Kwak, CH; Lee, B; Sir, JJ, 2012) |
| "Recurrent autonomic dysreflexia is uncommon in spinal cord injury patients and is usually caused by noxious stimuli that cannot be removed promptly, e." | 1.35 | Recurrent autonomic dysreflexia due to chronic aortic dissection in an adult male with cervical spinal cord injury. ( Hughes, PL; Oo, T; Soni, BM; Vaidyanathan, S, 2008) |
| "Nifedipine was administered in 20 mg doses hourly during right cardiac catheterization and was repeated after 1 hour until a decrease in systemic pressure occurred." | 1.29 | [Effect of large doses of nifedipine on pulmonary hypertension in patients with recurrent pulmonary thromboembolism]. ( Fijałkowska, A; Filipecki, S; Hajduk, B; Pałasiewicz, G; Polowiec, Z; Radomyski, A; Tomkowski, W, 1994) |
| "Vasospasm may be one of the causes of amaurosis fugax." | 1.28 | Recurrent attacks of amaurosis fugax treated with calcium channel blocker. ( Teman, AJ; Winterkorn, JM, 1991) |
| "Although withdrawal symptoms have been reported following abrupt cessation of therapy with some cardiovascular drugs, there is no detailed report on similar complications of the cessation of therapy with calcium antagonists." | 1.27 | Rebound of vasospastic angina after cessation of long-term treatment with nifedipine. ( Gagnon, RM; Lemire, JG; Lette, J; Morissette, M, 1984) |
| "The mean degree of stenosis was reduced from 77 +/- 12% to 29 +/- 15% and the mean systolic pressure gradient from 78 +/- 18 to 25 +/- 9 mmHg." | 1.27 | Role of percutaneous transluminal coronary angioplasty in patients with variant angina and coexistent coronary stenosis refractory to maximal medical therapy. ( Brücke, P; Herbinger, W; Leisch, F, 1984) |
| "Gynecomastia is a reaction that is not usually associated with calcium channel blocker therapy." | 1.27 | Gynecomastia associated with calcium channel blocker therapy. ( Bosco, LA; Tanner, LA, 1988) |
| "Thus nifedipine appears to be an efficacious agent in the treatment of refractory rest angina in patients with obstructive coronary artery disease." | 1.26 | Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease. ( Banka, VS; Bodenheimer, MM; Feldman, M; Helfant, RH; Moses, JW; Wertheimer, JH, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (39.24) | 18.7374 |
| 1990's | 32 (40.51) | 18.2507 |
| 2000's | 11 (13.92) | 29.6817 |
| 2010's | 5 (6.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leung, WD | 1 |
| Sherman, S | 1 |
| Catalano, LN | 1 |
| Villar Diaz, M | 1 |
| Vázquez Guzmán, M | 1 |
| Negron, I | 1 |
| Rivera Rosa, E | 1 |
| Klin, B | 1 |
| Efrati, Y | 1 |
| Berkovitch, M | 1 |
| Abu-Kishk, I | 1 |
| Vaidyanathan, S | 1 |
| Hughes, PL | 1 |
| Oo, T | 1 |
| Soni, BM | 1 |
| Kiernan, TJ | 1 |
| Yan, BP | 1 |
| Gupta, V | 1 |
| Garasic, JM | 1 |
| Flick, AA | 1 |
| de la Torre, L | 1 |
| Roca, LE | 1 |
| Istwan, N | 2 |
| Rhea, D | 2 |
| Desch, C | 1 |
| González-Quintero, VH | 1 |
| Kim, SM | 1 |
| Kwak, CH | 1 |
| Lee, B | 1 |
| Kim, SB | 1 |
| Sir, JJ | 1 |
| Cho, WH | 1 |
| Choi, SK | 1 |
| Perrotti, P | 1 |
| Bove, A | 1 |
| Antropoli, C | 1 |
| Molino, D | 1 |
| Antropoli, M | 1 |
| Balzano, A | 1 |
| De Stefano, G | 1 |
| Attena, F | 1 |
| Burashnikov, A | 1 |
| Antzelevitch, C | 1 |
| Fleming, A | 1 |
| Bonebrake, R | 1 |
| Coleman, S | 1 |
| Stanziano, G | 1 |
| Colman, N | 1 |
| Wieling, W | 1 |
| Wilde, AA | 1 |
| Slim, K | 1 |
| Siproudhis, L | 1 |
| Ho, KS | 1 |
| Ho, YH | 1 |
| Széplaki, G | 1 |
| Varga, L | 1 |
| Osváth, L | 1 |
| Karádi, I | 1 |
| Füst, G | 1 |
| Farkas, H | 1 |
| Bahamondes, C | 1 |
| Godoy, J | 1 |
| Shinohara, Y | 1 |
| Tohgi, H | 1 |
| Hirai, S | 1 |
| Terashi, A | 1 |
| Fukuuchi, Y | 1 |
| Yamaguchi, T | 1 |
| Okudera, T | 1 |
| Stone, PH | 3 |
| Turi, ZG | 1 |
| Muller, JE | 3 |
| Leisch, F | 1 |
| Herbinger, W | 1 |
| Brücke, P | 1 |
| Antman, EM | 1 |
| Kurnik, PB | 1 |
| Spadaro, JJ | 1 |
| Nordlicht, SM | 1 |
| Tiefenbrunn, AJ | 1 |
| Ludbrook, PA | 1 |
| Honda, T | 1 |
| Sampi, K | 1 |
| Hattori, M | 1 |
| Lette, J | 1 |
| Gagnon, RM | 1 |
| Lemire, JG | 1 |
| Morissette, M | 1 |
| Waters, DD | 1 |
| Bouchard, A | 1 |
| Théroux, P | 1 |
| Vaisrub, S | 1 |
| Kay, R | 1 |
| Blake, J | 1 |
| Rubin, D | 1 |
| Moses, JW | 1 |
| Wertheimer, JH | 1 |
| Bodenheimer, MM | 1 |
| Banka, VS | 1 |
| Feldman, M | 1 |
| Helfant, RH | 1 |
| Hess, OM | 1 |
| Graf, C | 1 |
| Frey, R | 1 |
| Dettli, R | 1 |
| Siegenthaler, W | 1 |
| Bertrand, ME | 1 |
| Lablanche, JM | 1 |
| Tilmant, PY | 1 |
| Tanne, D | 1 |
| Reicher-Reiss, H | 5 |
| Boyko, V | 4 |
| Behar, S | 7 |
| Jost, S | 1 |
| Deckers, J | 1 |
| Nikutta, P | 1 |
| Reiber, JH | 1 |
| Rafflenbeul, W | 2 |
| Wiese, B | 1 |
| Hecker, H | 1 |
| Lichtlen, P | 1 |
| Goldbourt, U | 4 |
| Barbash, G | 1 |
| Modan, B | 1 |
| Tsimmerman, IaS | 1 |
| Budnik, IuB | 1 |
| Syman, LN | 1 |
| Pałasiewicz, G | 1 |
| Tomkowski, W | 1 |
| Hajduk, B | 1 |
| Fijałkowska, A | 1 |
| Radomyski, A | 1 |
| Filipecki, S | 1 |
| Polowiec, Z | 1 |
| Rabinowitz, B | 1 |
| Zion, M | 1 |
| Kaplinsky, E | 3 |
| Abinader, E | 1 |
| Agmon, J | 1 |
| Friedman, Y | 1 |
| Kishon, Y | 1 |
| Palant, A | 1 |
| Winterkorn, JM | 2 |
| Kupersmith, MJ | 1 |
| Wirtschafter, JD | 1 |
| Forman, S | 1 |
| Snedkova, LV | 1 |
| Hoberg, E | 3 |
| Ishikawa, K | 2 |
| Nakai, S | 1 |
| Takenaka, T | 2 |
| Kanamasa, K | 2 |
| Hama, J | 1 |
| Ogawa, I | 1 |
| Yamamoto, T | 1 |
| Oyaizu, M | 1 |
| Kimura, A | 2 |
| Yamamoto, K | 1 |
| Yabushita, H | 1 |
| Katori, R | 1 |
| Gallagher, MM | 1 |
| Hart, CM | 1 |
| Vaughan, CJ | 1 |
| Fennell, WH | 1 |
| Messerli, FH | 1 |
| Mandelzweig, L | 3 |
| Jonas, M | 1 |
| Haim, M | 1 |
| Gottlieb, S | 1 |
| Hod, H | 1 |
| Miyataka, M | 1 |
| Ilgenli, T | 1 |
| Atilla, G | 1 |
| Baylas, H | 1 |
| Hansen, JF | 1 |
| Kuo, M | 1 |
| Winiarski, N | 1 |
| Garella, S | 1 |
| Mazur, NA | 1 |
| Vasil'eva, NN | 1 |
| Pavlova, TS | 1 |
| Kul'ginskaia, IV | 1 |
| Zhdanova, SM | 1 |
| Tam, IM | 1 |
| Wandres, DL | 1 |
| Ebner, F | 1 |
| Persson, S | 1 |
| Kübler, W | 3 |
| Knyshov, GV | 1 |
| Vykhovaniuk, IV | 1 |
| Tkhor, NV | 1 |
| Korchinskaia, OI | 1 |
| Stroganova, NP | 1 |
| Furkalo, SN | 1 |
| Rogers, WJ | 1 |
| Babb, JD | 1 |
| Baim, DS | 1 |
| Chesebro, JH | 1 |
| Gore, JM | 1 |
| Roberts, R | 2 |
| Williams, DO | 1 |
| Frederick, M | 1 |
| Passamani, ER | 1 |
| Braunwald, E | 1 |
| Teman, AJ | 1 |
| Barbaro, G | 1 |
| Murri, G | 1 |
| Profenna, LM | 1 |
| Avella, A | 1 |
| Kreuzer, J | 1 |
| von Hodenberg, E | 1 |
| Jahn, L | 1 |
| Sharma, SN | 1 |
| Iyengar, SS | 1 |
| Hegde, KP | 1 |
| Kivity, S | 1 |
| Yarchovsky, J | 1 |
| Morrison, DA | 1 |
| Gay, RG | 1 |
| Feldshon, D | 1 |
| Sampliner, RE | 1 |
| Hermesh, H | 1 |
| Molcho, A | 1 |
| Aizenberg, D | 1 |
| Munitz, H | 1 |
| Meyer, J | 2 |
| Merx, W | 1 |
| Dörr, R | 1 |
| Erbel, R | 2 |
| von Essen, R | 1 |
| Lambertz, H | 1 |
| Bethge, C | 1 |
| Schmitz, HJ | 1 |
| Bardos, P | 1 |
| Minale, C | 1 |
| Hanger, KH | 1 |
| Assey, ME | 1 |
| Slogoff, S | 1 |
| Keats, AS | 1 |
| Whitworth, HB | 1 |
| Roubin, GS | 1 |
| Hollman, J | 1 |
| Meier, B | 1 |
| Leimgruber, PP | 1 |
| Douglas, JS | 1 |
| King, SB | 1 |
| Gruentzig, AR | 1 |
| Sanders, M | 1 |
| Shimizu, Y | 1 |
| Tanaka, T | 1 |
| Takayama, Y | 1 |
| Hayashi, T | 1 |
| Ito, Y | 1 |
| Abe, M | 1 |
| Matsuda, M | 1 |
| Ida, T | 1 |
| Sakakibara, T | 1 |
| Obunai, Y | 1 |
| Pop, T | 1 |
| Meinertz, T | 1 |
| Olshausen, KV | 1 |
| Treese, N | 1 |
| Henrichs, KJ | 1 |
| Schuster, CJ | 1 |
| Rupprecht, HJ | 1 |
| Schlürmann, W | 1 |
| Tanner, LA | 1 |
| Bosco, LA | 1 |
| Friedmann, J | 1 |
| Reicher, H | 1 |
| Moss, AJ | 1 |
| Madias, JE | 1 |
| Eisenberg, PR | 1 |
| Lee, RG | 1 |
| Biello, DR | 1 |
| Geltman, EM | 1 |
| Jaffe, AS | 1 |
| Nakano, T | 1 |
| Konishi, T | 1 |
| Takezawa, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000505] | Phase 3 | 0 participants | Interventional | 1983-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for nifedipine and Recrudescence
| Article | Year |
|---|---|
Endoscopic approach to the patient with motility disorders of the bile duct and sphincter of Oddi.
Topics: Bile Ducts; Botulinum Toxins, Type A; Cholangiopancreatography, Endoscopic Retrograde; Dilatation; H | 2013 |
[Anal fissure. Which first line treatment?].
Topics: Botulinum Toxins, Type A; Dilatation; Diltiazem; Evidence-Based Medicine; Fecal Incontinence; Fissur | 2004 |
The effects of calcium antagonists after PTCA.
Topics: Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Clinical Trials as Topic; Constriction, Pa | 1995 |
Calcium-channel blockers and gingival hyperplasia.
Topics: Aged; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Female; Gingival Hyperplasia; Hu | 1992 |
Myocardial infarction. Secondary prevention with nifedipine.
Topics: Female; Heart; Humans; Male; Myocardial Infarction; Nifedipine; Recurrence; Risk Factors | 1991 |
Calcium antagonists in secondary prevention after myocardial infarction.
Topics: Calcium Channel Blockers; Diltiazem; Female; Humans; Male; Meta-Analysis as Topic; Myocardial Infarc | 1991 |
Prevention of restenosis after PTCA: role of calcium antagonists.
Topics: Aged; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Coronary Disease; Diltiazem; Double- | 1991 |
Calcium-antagonists in preventing restenosis following coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease | 1991 |
Preventing recurrent myocardial infarction. Use of calcium-channel blockers.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Electrocardiography; Humans; Myocardi | 1988 |
Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Humans; Myocardial Infarction; Nifedi | 1987 |
28 trials available for nifedipine and Recrudescence
| Article | Year |
|---|---|
An examination of the clinical benefits and cost-effectiveness of tocolytic replacement following recurrent preterm labor.
Topics: Adult; Cost-Benefit Analysis; Female; Humans; Nifedipine; Obstetric Labor, Premature; Pregnancy; Pre | 2010 |
Topical nifedipine with lidocaine ointment vs. active control for treatment of chronic anal fissure: results of a prospective, randomized, double-blind study.
Topics: Administration, Topical; Adolescent; Adult; Aged; Chronic Disease; Double-Blind Method; Drug Combina | 2002 |
Randomized clinical trial comparing oral nifedipine with lateral anal sphincterotomy and tailored sphincterotomy in the treatment of chronic anal fissure.
Topics: Administration, Oral; Adult; Anal Canal; Calcium Channel Blockers; Chronic Disease; Double-Blind Met | 2005 |
Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA Study). 1. Design and results at enrollment.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Cerebral Infarcti | 2007 |
Stroke risk after anterior wall acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Topics: Aged; Atrial Fibrillation; Cerebrovascular Disorders; Chronic Disease; Female; Follow-Up Studies; Hu | 1995 |
Influence of the selection of angiographic projections on the results of coronary angiographic follow-up trials. International Nifedipine Trial on Antiatherosclerotic Therapy Investigators.
Topics: Analysis of Variance; Coronary Angiography; Coronary Disease; Disease Progression; Double-Blind Meth | 1995 |
Twenty-five-year mortality rate decrease in patients in Israel with a first episode of acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial Study Group. Israeli Thrombolytic Survey Group.
Topics: Adult; Age Distribution; Aged; Cohort Studies; Female; Hospital Mortality; Humans; Israel; Male; Mid | 1995 |
Immediate and long-term prognostic significance of a first anterior versus first inferior wall Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group.
Topics: Aged; Confounding Factors, Epidemiologic; Female; Humans; Logistic Models; Male; Middle Aged; Multiv | 1993 |
[A trial of the use of nifedipine for preventing relapses in affective and schizoaffective psychoses].
Topics: Adult; Affective Disorders, Psychotic; Aged; Chronic Disease; Female; Humans; Male; Middle Aged; Nif | 1996 |
Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Diltiazem; Female; Humans; Male; Middle Aged; Multi | 1997 |
Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Topics: Adult; Age Factors; Aged; Calcium Channel Blockers; Female; Follow-Up Studies; Humans; Male; Middle | 1998 |
Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction.
Topics: Aged; Calcium Channel Blockers; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; | 1998 |
Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era. SPRINT and the Israeli Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cause of Death; Cohort Studies; Confidence Intervals; C | 1998 |
Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group.
Topics: Calcium Channel Blockers; Cause of Death; Diltiazem; Female; Humans; Male; Middle Aged; Myocardial I | 1999 |
Secondary prevention with calcium antagonists after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Diltiazem; Female; Humans; Male; Middle Aged; Myocardial I | 1992 |
[Calcium antagonists. The prevention of a recurrent myocardial infarct and sudden death].
Topics: Calcium Channel Blockers; Death, Sudden, Cardiac; Drug Therapy, Combination; Electrocardiography, Am | 1992 |
Myocardial infarction. Secondary prevention with nifedipine.
Topics: Female; Heart; Humans; Male; Myocardial Infarction; Nifedipine; Recurrence; Risk Factors | 1991 |
Prevention of restenosis after PTCA: role of calcium antagonists.
Topics: Aged; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Coronary Disease; Diltiazem; Double- | 1991 |
Calcium-antagonists in preventing restenosis following coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease | 1991 |
Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators.
Topics: Aged; Aspirin; Coronary Angiography; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Co | 1991 |
[Nifedipine in secondary prevention after myocardial infarction. SPRINT Study Group].
Topics: Clinical Trials as Topic; Coronary Care Units; Double-Blind Method; Humans; Israel; Multicenter Stud | 1989 |
Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Meto
Topics: Aged; Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Coronary Care Units; Double-Blind | 1986 |
Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon; Coronary Disease; Humans; Middle Aged; Nifedipine; Patient Compli | 1986 |
Preventing recurrent myocardial infarction. Use of calcium-channel blockers.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Electrocardiography; Humans; Myocardi | 1988 |
Combination of calcium channel blocker and thrombolytic therapy in acute myocardial infarction.
Topics: Adult; Aged; Calcium Channel Blockers; Capsules; Clinical Trials as Topic; Coronary Circulation; Dou | 1988 |
Two cases of sudden death documented by Holter monitor during Secondary Prevention Reinfarction Nifedipine Trial (SPRINT).
Topics: Aged; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Electrocardiography; Female; Fol | 1986 |
Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Humans; Myocardial Infarction; Nifedi | 1987 |
Chest pain after nontransmural infarction: the absence of remediable coronary vasospasm.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Vasospasm; Creatine Kinase; Double-Blind M | 1985 |
46 other studies available for nifedipine and Recrudescence
| Article | Year |
|---|---|
Pregnancy outcomes and successful rate of nifedipine therapeutic protocol implementation in a hospital of San Juan.
Topics: Adolescent; Adult; Dexamethasone; Drug Administration Schedule; Drug Evaluation; Female; Fetal Membr | 2013 |
Anal fissure in children: a 10-year clinical experience with nifedipine gel with lidocaine.
Topics: Administration, Topical; Adolescent; Anesthetics, Local; Child; Child, Preschool; Drug Combinations; | 2016 |
Recurrent autonomic dysreflexia due to chronic aortic dissection in an adult male with cervical spinal cord injury.
Topics: Adrenergic alpha-Antagonists; Aortic Rupture; Autonomic Dysreflexia; Calcium Channel Blockers; Cervi | 2008 |
Unusual case of recurrent renal artery stenosis: lessons to learn.
Topics: Adult; Angiography; Enalapril; Graft Occlusion, Vascular; Humans; Hypertension; Male; Nifedipine; Re | 2009 |
A case of severe coronary spasm associated with 5-fluorouracil chemotherapy.
Topics: Aged, 80 and over; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Calcium Channel | 2012 |
Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity.
Topics: Acetylcholine; Action Potentials; Animals; Atrial Fibrillation; Atrial Function; Calcium Channel Blo | 2003 |
Pregnancy and economic outcomes in patients treated for recurrent preterm labor.
Topics: Administration, Oral; Adult; Case-Control Studies; Cost-Benefit Analysis; Costs and Cost Analysis; F | 2004 |
A patient with recurrent syncope and ST-elevation on the electrocardiogram.
Topics: Calcium Channel Blockers; Coronary Disease; Electrocardiography; Female; Humans; Middle Aged; Nifedi | 2004 |
Deep venous thrombosis associated with acquired angioedema type II in a patient heterozygous for the mutation of factor V Leiden: effective treatment and follow-up for four years.
Topics: Acenocoumarol; Aged; Angioedema; Autoantibodies; Complement C1 Inhibitor Protein; Danazol; Factor V; | 2006 |
[Cyclosporine-induced gingival hyperplasia: report of one case].
Topics: Biofilms; Calcium Channel Blockers; Cyclosporine; Gingiva; Gingival Hyperplasia; Humans; Immunosuppr | 2007 |
Efficacy of nifedipine therapy for refractory angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; | 1982 |
Role of percutaneous transluminal coronary angioplasty in patients with variant angina and coexistent coronary stenosis refractory to maximal medical therapy.
Topics: Adult; Angina Pectoris, Variant; Angiography; Angioplasty, Balloon; Aspirin; Constriction, Pathologi | 1984 |
Nifedipine therapy for coronary vasospasm.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Disease; Coronary Vasospasm; Female; Humans; Mal | 1983 |
Prolonged coronary vasoconstrictor effect of ergonovine maleate.
Topics: Cardiac Catheterization; Coronary Angiography; Coronary Circulation; Coronary Vasospasm; Dose-Respon | 1984 |
[Combination therapy of vinca alkaloids and nicardipine in non-Hodgkin's lymphoma with resistant to various antineoplastic agents].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Drug Therapy, Combination; Fe | 1983 |
Rebound of vasospastic angina after cessation of long-term treatment with nifedipine.
Topics: Adult; Angina Pectoris, Variant; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine | 1984 |
Spontaneous remission is a frequent outcome of variant angina.
Topics: Adult; Angina Pectoris, Variant; Coronary Angiography; Coronary Vasospasm; Diltiazem; Electrocardiog | 1983 |
Recurrence of variant angina after bypass surgery.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Artery Bypass; Humans; Nifedipine; Recurrence | 1980 |
Possible coronary spasm rebound to abrupt nifedipine withdrawal.
Topics: Aged; Coronary Vasospasm; Humans; Male; Nifedipine; Pyridines; Recurrence; Substance Withdrawal Synd | 1982 |
Nifedipine therapy for recurrent ischemic pain following myocardial infarction.
Topics: Aged; Angina Pectoris; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nifedipine; Pyridin | 1982 |
Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged | 1981 |
[Coronary artery spasms with normal coronary arteries as the cause of recurrent ventricular fibrillations].
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Angiography; Electrocardiography; Humans; Male; | 1981 |
Treatment of spasm of the coronary artery with nifedipine.
Topics: Adult; Aged; Coronary Circulation; Coronary Vasospasm; Coronary Vessels; Humans; Injections, Intra-A | 1980 |
[The effect of calcium antagonists and beta-adrenoblockaders on disordered stomach functions in patients with duodenal peptic ulcer].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Drug Evaluation; Duodenal | 1994 |
[Effect of large doses of nifedipine on pulmonary hypertension in patients with recurrent pulmonary thromboembolism].
Topics: Adult; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nifedipine; Pulmonary Embol | 1994 |
Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers.
Topics: Adult; Aged; Blindness; Carotid Stenosis; Embolism; Female; Humans; Male; Middle Aged; Nifedipine; R | 1993 |
Rapid recurrence of pulmonary hypertension following cessation of nifedipine.
Topics: Adult; Female; Humans; Hypertension, Pulmonary; Nifedipine; Recurrence; Vasodilator Agents | 1998 |
Nifedipine after acute myocardial infarction--sola dosis facit venenum: only the dose determines the harm.
Topics: Calcium Channel Blockers; Humans; Myocardial Infarction; Nifedipine; Recurrence; Risk Assessment | 1998 |
Effectiveness of periodontal therapy in patients with drug-induced gingival overgrowth. Long-term results.
Topics: Adult; Age Factors; Calcium Channel Blockers; Cyclosporine; Dental Plaque Index; Dental Prophylaxis; | 1999 |
Nonthrombocytopenic purpura associated sequentially with nifedipine and diltiazem.
Topics: Aged; Diltiazem; Female; Humans; IgA Vasculitis; Nifedipine; Recurrence; Vasculitis, Leukocytoclasti | 1992 |
[Effects of calcium antagonists on the pattern of intracardiac hemodynamics and functional state of the myocardium in patients with angina pectoris relapsing after aortocoronary bypass operation].
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Artery Bypass; Coronary Disease; Hemodyna | 1991 |
Recurrent attacks of amaurosis fugax treated with calcium channel blocker.
Topics: Aged; Arterial Occlusive Diseases; Blindness; Carotid Artery Diseases; Carotid Artery, Internal; Hum | 1991 |
[The role of therapy with a Ca++ antagonists (nifedipine) in the long-term prognosis of hypertensive patients with previous myocardial infarction].
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Myocardial Infarcti | 1990 |
[Recurrent ventricular fibrillation in a patient with angiographically normal coronary arteries and intermittent ST segment elevation].
Topics: Adult; Angina Pectoris; Angiocardiography; Drug Therapy, Combination; Electrocardiography; Humans; M | 1990 |
Nifedipine induced hyperglycaemia.
Topics: Administration, Sublingual; Glucose Tolerance Test; Humans; Hyperglycemia; Hypertension; Male; Middl | 1990 |
Relapsing anaphylaxis to bee sting in a patient treated with beta-blocker and Ca blocker.
Topics: Anaphylaxis; Animals; Bees; Drug Therapy, Combination; Humans; Insect Bites and Stings; Male; Middle | 1990 |
Severe pulmonary hypertension in a patient with Whipple's disease.
Topics: Drug Combinations; Furosemide; Heart Failure; Heart Murmurs; Humans; Hypertension, Pulmonary; Male; | 1985 |
The calcium antagonist nifedipine in recurrent neuroleptic malignant syndrome.
Topics: Adult; Calcium Channels; Female; Humans; Neuroleptic Malignant Syndrome; Nifedipine; Recurrence | 1988 |
Sequential intervention procedures after intracoronary thrombolysis; balloon dilatation, bypass surgery, and medical treatment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angioplasty, Balloon; Anti-Arrhythmia Agents; Combined Mod | 1985 |
Angina after aortocoronary bypass grafting: combined medical therapy including nifedipine.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Coronary Artery Bypass; Drug Therapy, Com | 1985 |
Does chronic treatment with calcium entry blocking drugs reduce perioperative myocardial ischemia?
Topics: Administration, Oral; Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Artery Bypass; | 1988 |
Angiographic changes thirty minutes following percutaneous transluminal coronary angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon; Cineangiography; Coronary Angiography; Coronary Disease; Female; | 1985 |
Clinical experience of percutaneous transluminal coronary angioplasty--technique and results.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease; | 1985 |
Gynecomastia associated with calcium channel blocker therapy.
Topics: Aged; Calcium Channel Blockers; Diltiazem; Drug Administration Schedule; Gynecomastia; Humans; Male; | 1988 |
The long-term outcome of patients who suffered and survived an acute myocardial infarction in the midst of recurrent attacks of variant angina.
Topics: Angina Pectoris, Variant; Cardiac Catheterization; Drug Therapy, Combination; Electrocardiography; F | 1986 |
Potential prevention of myocardial rupture resulting from acute myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Female; Heart Rupture; Heart Septum; Heart Ventricles; Humans; Hyperte | 1985 |